Avivomed Inc.
Biotechnology · Roseville, MN
BiotechnologySEC Form D
Avivomed Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 21, 2026, reporting $5,000,000 raised toward a $12,000,000 offering.
Incorporated in Delaware and based in Roseville, MN, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Avivomed Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Paul MazanecExecutive Officer · Director
- Mudit K. JainDirector
- Ketan PatelDirector
- Theresa C. PappasDirector
- Casper de ClercqDirector
- Douglas ReedDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised